Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy
Jd. Marshall et al., Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy, J ALLERG CL, 108(2), 2001, pp. 191-197
Background: Recent studies have demonstrated that bacterially derived immun
ostimulatory sequences (ISSs) of DNA can activate the mammalian innate immu
ne system and promote the development of T(H)1 cells. Promotion of T(H)1 im
munity by means of immunotherapy in allergic patients has led to the allevi
ation of symptoms that result from allergen-specific T(H)2 responses.
Objective: Our purpose was to investigate whether the T(H)1-enhancing prope
rties of ISSs could be used to alter the T(H)2-dominated immune response of
allergic PBMCs in vitro.
Methods: Ragweed protein-Iinked ISS (PLI) was generated from a specific, hi
ghly active 22-base ISS and Amb a 1, the immunodominant allergen in ragweed
pollen, to combine the T(H)1-enhancing properties of ISSs with allergen se
lectivity, and its activity was investigated in PBMC cultures from subjects
with ragweed allergy.
Results: PLI was markedly successful at reversing the dominant allergen-ind
uced T(H)2 profile while greatly enhancing IFN-gamma production. Delivering
ISSs in a linked form proved to be much more effective at modulating the r
esulting cytokine profile than delivering free ISSs in a mixture with unlin
ked Amb a 1. PLI also demonstrated cytokine-modulating properties, even whe
n used to stimulate cells that had already been primed for 6 days with Amb
a 1. The antigen specificity of the action of PLI was confirmed by the obse
rvations that PLI enhances Arab a 1-specific T-cell proliferation.
Conclusion: These data indicate that delivery of ISSs within an antigen-spe
cific context exhibits potent cytokine-modulating activity and, combined wi
th its reduced allergenicity, makes this molecule a strong candidate for us
e in improved immunotherapy applications.